An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management - Université de Lorraine Access content directly
Journal Articles Autoimmunity Reviews Year : 2022

An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management

Fichier principal
Vignette du fichier
S1568997221002950.pdf (409.73 Ko) Télécharger le fichier
Origin : Files produced by the author(s)

Dates and versions

hal-03504767 , version 1 (08-01-2024)

Licence

Attribution - NonCommercial

Identifiers

Cite

Paul Decker, Thomas Moulinet, F. Pontille, M. Cravat, Marcelo de Carvalho-Bittencourt, et al.. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management. Autoimmunity Reviews, 2022, 21 (3), pp.103013. ⟨10.1016/j.autrev.2021.103013⟩. ⟨hal-03504767⟩
71 View
1 Download

Altmetric

Share

Gmail Facebook X LinkedIn More